1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow HAE: new trials by email Literature Review of HAE trials Research Report on HAE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema avoralstat - Hereditary Angioedema, HAE | Phase 3 | Terminated | BioCryst Pharmaceuticals | 6 | 2015-12-01 | 2016-02-17 |
Angioedema (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hereditary Complement Deficiency Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Primary Immunodeficiency Diseases (1) · Skin Diseases (1) · Skin Diseases, Vascular (1) · Skin and Connective Tissue Diseases (1) · Urticaria (1) · Vascular Diseases (1)
avoralstat (1)
Belgium (1) · France (1)